Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry.

Reidy KJ, Hjorten R, Parekh RS.

Curr Opin Pediatr. 2018 Apr;30(2):252-259. doi: 10.1097/MOP.0000000000000603. Review.

2.

APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.

Mukamal KJ, Tremaglio J, Friedman DJ, Ix JH, Kuller LH, Tracy RP, Pollak MR.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):398-403. doi: 10.1161/ATVBAHA.115.305970. Epub 2015 Dec 3.

3.

APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults.

Gutiérrez OM, Limou S, Lin F, Peralta CA, Kramer HJ, Carr JJ, Bibbins-Domingo K, Winkler CA, Lewis CE, Kopp JB.

Kidney Int. 2018 Mar;93(3):727-732. doi: 10.1016/j.kint.2017.08.019. Epub 2017 Oct 14.

4.

APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.

Ng DK, Robertson CC, Woroniecki RP, Limou S, Gillies CE, Reidy KJ, Winkler CA, Hingorani S, Gibson KL, Hjorten R, Sethna CB, Kopp JB, Moxey-Mims M, Furth SL, Warady BA, Kretzler M, Sedor JR, Kaskel FJ, Sampson MG.

Nephrol Dial Transplant. 2017 Jun 1;32(6):983-990. doi: 10.1093/ndt/gfw061.

5.

Worldwide Frequencies of APOL1 Renal Risk Variants.

Nadkarni GN, Gignoux CR, Sorokin EP, Daya M, Rahman R, Barnes KC, Wassel CL, Kenny EE.

N Engl J Med. 2018 Dec 27;379(26):2571-2572. doi: 10.1056/NEJMc1800748. No abstract available.

PMID:
30586505
6.

An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.

Robertson CC, Gillies CE, Putler RKB, Ng D, Reidy KJ, Crawford B, Sampson MG.

Nephrol Dial Transplant. 2017 Dec 1;32(12):2051-2058. doi: 10.1093/ndt/gfw317.

7.

The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease.

Estrella MM, Parekh RS.

Semin Nephrol. 2017 Nov;37(6):520-529. doi: 10.1016/j.semnephrol.2017.07.005. Review.

PMID:
29110759
8.

Apolipoprotein L1 and Kidney Disease in African Americans.

Friedman DJ, Pollak MR.

Trends Endocrinol Metab. 2016 Apr;27(4):204-215. doi: 10.1016/j.tem.2016.02.002. Epub 2016 Mar 3. Review.

9.

APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).

Chen TK, Appel LJ, Grams ME, Tin A, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1765-1769. doi: 10.1161/ATVBAHA.117.309384. Epub 2017 Jun 1.

10.

APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.

Gutiérrez OM, Judd SE, Irvin MR, Zhi D, Limdi N, Palmer ND, Rich SS, Sale MM, Freedman BI.

Nephrol Dial Transplant. 2016 Apr;31(4):602-8. doi: 10.1093/ndt/gfv229. Epub 2015 Jul 6.

11.

Introduction: APOL1-Associated Kidney Disease.

Pollak MR.

Semin Nephrol. 2017 Nov;37(6):489. doi: 10.1016/j.semnephrol.2017.07.001. No abstract available.

PMID:
29110755
12.

JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.

Divers J, Núñez M, High KP, Murea M, Rocco MV, Ma L, Bowden DW, Hicks PJ, Spainhour M, Ornelles DA, Kleiboeker SB, Duncan K, Langefeld CD, Turner J, Freedman BI.

Kidney Int. 2013 Dec;84(6):1207-13. doi: 10.1038/ki.2013.173. Epub 2013 May 15.

13.

Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.

Freedman BI, Langefeld CD, Turner J, Núñez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J.

Kidney Int. 2012 Oct;82(7):805-11. doi: 10.1038/ki.2012.217. Epub 2012 Jun 13.

14.

APOL1 Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD.

Chen TK, Tin A, Peralta CA, Appel LJ, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1771-1777. doi: 10.2215/CJN.01180117. Epub 2017 Oct 19.

15.

A Brief History of APOL1: A Gene Evolving.

Friedman DJ.

Semin Nephrol. 2017 Nov;37(6):508-513. doi: 10.1016/j.semnephrol.2017.07.003. Review.

PMID:
29110757
16.

APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.

Jotwani V, Shlipak MG, Scherzer R, Parekh RS, Kao WH, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Parikh CR, Estrella MM.

Am J Kidney Dis. 2015 Jun;65(6):889-98. doi: 10.1053/j.ajkd.2015.02.329. Epub 2015 Apr 24.

17.

APOL1 G2 risk allele-clarifying nomenclature.

Zhang Z, Hao K, Ross MJ, Murphy B, Menon MC.

Kidney Int. 2017 Aug;92(2):518-519. doi: 10.1016/j.kint.2017.05.009. No abstract available.

PMID:
28709608
18.

APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.

Chen TK, Estrella MM, Vittinghoff E, Lin F, Gutierrez OM, Kramer H, Lewis CE, Kopp JB, Allen NB, Winkler CA, Bibbins-Domingo KB, Peralta CA.

Kidney Int. 2017 Oct;92(4):964-971. doi: 10.1016/j.kint.2017.03.028. Epub 2017 May 23.

19.

APOL1 Kidney Disease Risk Variants: An Evolving Landscape.

Dummer PD, Limou S, Rosenberg AZ, Heymann J, Nelson G, Winkler CA, Kopp JB.

Semin Nephrol. 2015 May;35(3):222-36. doi: 10.1016/j.semnephrol.2015.04.008. Review.

20.

Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Beckerman P, Bi-Karchin J, Park AS, Qiu C, Dummer PD, Soomro I, Boustany-Kari CM, Pullen SS, Miner JH, Hu CA, Rohacs T, Inoue K, Ishibe S, Saleem MA, Palmer MB, Cuervo AM, Kopp JB, Susztak K.

Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.

Supplemental Content

Support Center